Atıf Formatları
A Dilemma in Staging of Esophageal Cancer: How Should We Stage ypT0 N2 M0 Esophageal Cancer after Neoadjuvant Therapy?
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

S. CELIK Et Al. , "A Dilemma in Staging of Esophageal Cancer: How Should We Stage ypT0 N2 M0 Esophageal Cancer after Neoadjuvant Therapy?," Case reports in pathology , vol.2015, pp.158626, 2015

CELIK, S. Et Al. 2015. A Dilemma in Staging of Esophageal Cancer: How Should We Stage ypT0 N2 M0 Esophageal Cancer after Neoadjuvant Therapy?. Case reports in pathology , vol.2015 , 158626.

CELIK, S., Erten, R., BATUR, A., & SUVAK, B., (2015). A Dilemma in Staging of Esophageal Cancer: How Should We Stage ypT0 N2 M0 Esophageal Cancer after Neoadjuvant Therapy?. Case reports in pathology , vol.2015, 158626.

CELIK, S Et Al. "A Dilemma in Staging of Esophageal Cancer: How Should We Stage ypT0 N2 M0 Esophageal Cancer after Neoadjuvant Therapy?," Case reports in pathology , vol.2015, 158626, 2015

CELIK, S Et Al. "A Dilemma in Staging of Esophageal Cancer: How Should We Stage ypT0 N2 M0 Esophageal Cancer after Neoadjuvant Therapy?." Case reports in pathology , vol.2015, pp.158626, 2015

CELIK, S. Et Al. (2015) . "A Dilemma in Staging of Esophageal Cancer: How Should We Stage ypT0 N2 M0 Esophageal Cancer after Neoadjuvant Therapy?." Case reports in pathology , vol.2015, p.158626.

@article{article, author={S CELIK Et Al. }, title={A Dilemma in Staging of Esophageal Cancer: How Should We Stage ypT0 N2 M0 Esophageal Cancer after Neoadjuvant Therapy?}, journal={Case reports in pathology}, year=2015, pages={158626} }